Health & Environment
Centre Caps Trade Margins On Non-Scheduled Cancer Drugs At 30% Of MRP
The Hindu2h
THE BRIEF
1
The Union government capped trade margins at 30% of the maximum retail price for all non-scheduled anti-cancer drugs to reduce patient out-of-pocket expenditure.
2
An expert committee under the Directorate General of Health Services will finalise the medicine list, covering branded, generic, domestic, imported, and patented products.
3
The National Pharmaceutical Pricing Authority found average trade mark-ups of around 170% reaching up to 700%, with the new cap expected to save patients ₹2,500 crore annually.